Using FISH-based techniques, rearrangements of the immunoglobulin heavy-chain (IgH) locus at 14q32 have been found in the majority of cases of multiple myeloma (MM). Some of these IgH translocations are recurrent and we have characterized the genomic breakpoints of seven t(4;14) translocations from MM patients, using a combination of vectorette and conventional polymerase chain reaction methods, the aim being to understand the molecular mechanism leading to MM. Conventionally, the chromosome 14q32 breakpoints in these reciprocal translocations are believed to be located in the IgH mu switch (S) region and a further downstream S region with deletion of intervening DNA occurring as a result of aberrant class switch recombination (CSR); this was seen in five of the cases analysed. However, in two patients it was possible to demonstrate that the rearranged hybrid switch region sequence was joined to DNA from chromosome 4p16, suggesting that IgH translocations can occur in B cells that have already undergone legitimate CSR. The complex nature of these rearrangements leads us to speculate that primary IgH translocations may occur at different time points in the development in MM plasma cells, either at the time of physiological CSR or at a later stage, possibly involving a different mechanism.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206335DOI Listing

Publication Analysis

Top Keywords

igh translocations
12
breakpoints t414
8
multiple myeloma
8
switch region
8
translocations occur
8
igh
5
translocations
5
genomic characterization
4
characterization chromosomal
4
chromosomal breakpoints
4

Similar Publications

Burkitt lymphoma.

Hum Pathol

December 2024

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

Burkitt lymphoma is a mature aggressive B-cell neoplasm with distinctive clinical and morphologic features, a germinal center B-cell immunophenotype, a high proliferation index and MYC rearrangement with an immunoglobulin gene partner. Initially described in equatorial Africa by a surgeon, Denis Burkitt, African (endemic) Burkitt lymphoma was the first neoplasm shown to be associated with a virus, Epstein-Barr virus (EBV), and the first neoplasm shown to be associated with a chromosomal translocation, IGH::MYC. In this article, we provide a brief historical introduction of Burkitt lymphoma, followed by a review of all aspects of this neoplasm including pathogenesis, clinical presentation, morphology, immunophenotype, cytogenetics and molecular findings.

View Article and Find Full Text PDF
Article Synopsis
  • Sporadic Burkitt lymphoma (BL) usually affects the abdomen, especially the ileocecal area, while stomach involvement is extremely rare.
  • This case report highlights a unique instance of atypical Burkitt lymphoma that originated in the stomach, which has not been previously documented.
  • Diagnostic tests showed positive markers like CD20 and the c-MYC gene rearrangement, but the common translocations related to Burkitt lymphoma were not present.
View Article and Find Full Text PDF

Increased c-MYC Expression Associated with Active IGH Locus Rearrangement: An Emerging Role for c-MYC in Chronic Lymphocytic Leukemia.

Cancers (Basel)

November 2024

Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 7276/INSERM U1262, Université de Limoges, 87000 Limoges, France.

Article Synopsis
  • * Its overexpression is particularly linked to CLL cases with unmutated immunoglobulin heavy chain variable (IGHV) genes, causing significant DNA damage and contributing to a more aggressive disease.
  • * The review emphasizes c-MYC's dual role in promoting rapid cell proliferation and driving genetic recombination, suggesting it could be a promising target for new therapeutic strategies in CLL.
View Article and Find Full Text PDF

Cyclin D1-negative mantle cell lymphoma (MCL) is regarded as a B-cell neoplasm that has morphologic and immunophenotypic findings indistinguishable from typical MCL. These neoplasms lack cyclin D1 overexpression by immunohistochemistry and t(11;14)(q13;q32)/IGH::CCND1. Since cyclin D1-negative MCL was first recognized by gene expression profiling in 2003, there has been diagnostic confusion regarding this entity, mostly attributable to a lack of diagnostic tools to recognize these neoplasms in most clinical laboratories.

View Article and Find Full Text PDF
Article Synopsis
  • Follicular lymphoma (FL) is a common type of slow-growing B-cell lymphoma characterized by the t(14;18) translocation and presents a diverse range of clinical outcomes, with most patients initially having a favorable prognosis but facing incurable relapses and potential transformation to aggressive forms of lymphoma.
  • The review analyzes research on molecular biomarkers related to FL transformation and patient outcomes, examining 283 studies published between January 1984 and September 2024, adhering to PRISMA guidelines.
  • It categorizes biomarkers into groups based on their effects on prognosis or transformation risk, identifying various genetic, gene expression, and microRNA markers, while highlighting ongoing challenges in predicting transformation risk for FL patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!